Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001879713-25-000002
Filing Date
2025-10-23
Accepted
2025-10-23 18:43:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6084
  Complete submission text file 0001879713-25-000002.txt   7796
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Subject) CIK: 0001702123 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93041 | Film No.: 251413972
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 15TH FLOOR 33 CAVENDISH SQUARE LONDON X0 W1G 0PW
Business Address 15TH FLOOR 33 CAVENDISH SQUARE LONDON X0 W1G 0PW 0044(0)2079078566
Tejara Capital Ltd (Filed by) CIK: 0001879713 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G